Inzhesta is hormones of gonads. Gestagena. The indications
Disturbance connected with deficiency of progesterone.
Oral administration
Gynecologic: the violations connected with deficiency of progesterone namely:
- premenstrual syndrome;
- violation of a menstrual cycle (dizovulyatsiya, anovulyatsiya).
Obstetric:
- prevention of a usual abortion or threat of an abortion against the background of lyuteinovy insufficiency;
- threat of premature births.
- 1 capsule contains
progesterone micronized 200 mg;
- excipients: lecithin, sunflower oil;
- structure of a cover of the capsule: gelatin, glycerin, titan dioxide (E 171).
Contraindication
Hypersensitivity to medicine components.
Heavy abnormal liver functions.
Suspect or is confirmed toa neoplasia of a breast or genitals.
not diagnosed vaginal bleedings.
Unsuccessful or incomplete abortion.
Thrombophlebitis. Thromboembolic violations.
Cerebral hemorrhage.
Porphyria.
Route of administration
Oral administration
In most cases the average daily dose makes 200-300 mg in 1 or 2 receptions (200 mg in the evening, before going to bed, and 100 mg in the morning if there is such need).
Capsule to enter Intravaginalnoye's
application
deeply into a vagina in a dorsal decubitus.Before each use of medicine needs to wash up carefully hands that there is no detergent left on hands.
dose averages 200 mg of progesterone a day (1 capsule on 200 mg or 2 capsules on 100 mg, in 2 receptions, in the morning and in the evening which enter deeply into a vagina, if necessary - by means of the applicator). The dose can be increased depending on reaction of the patient.
At partial insufficiency of a lyuteinovy phase (dizovulyatsiya, violation of a menstrual cycle) the daily dose makes 200 mg within 10 days (usually from the 17th to the twenty sixth day of a cycle).
Feature of application
Treatment in the recommended doses has no contraceptive effect.
If the course of treatment beginsvery much early - at the beginning of a monthly cycle, especially till 15th day of a cycle, reduction of a cycle or bleeding can be observed.
in case of uterine bleedings not to appoint medicine without specification of their reason, in particular at endometrium inspection.
Pregnant toUse of the medicine Inzhesta® is not contraindicated to
at pregnancy, including in the first weeks Children
Clinical data on use of medicine to children are absent.
Driversdrowsiness and dizziness Is possible
. Overdose
Symptoms of overdose can be shown by symptomatology of side reactions, including drowsiness, dizziness, euphoria, a dysmenorrhea, reduction of duration of a cycle, a metrorrhagia.
Side effects
from a reproductive system and mammary glands: change of periods, an amenorrhea, the alternating bleedings.
from nervous system: drowsiness, short-term feeling of dizziness.
from digestive system: vomiting, diarrhea, lock.
Storage conditionsto Store
at a temperature not above 25 °C. to Store
out of children's reach.
Characteristics | |
Active ingredients | Progesterone |
Amount of active ingredient | 200 mg |
Applicant | Pharmak |
Code of automatic telephone exchange | G03DA04 Progesterone |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | box |
Producer | PUBLIC JOINT STOCK COMPANY PHARMAK |
Quantity in packing | 20 capsules |
Release form | capsules for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Inzhesta |
Inzhesta kaps. soft 200 mg No. 20
- Product Code: 180000
- In Stock
- Ready to ship
-
$43.86